Varex Imaging (NASDAQ:VREX) Issues Q3 2026 Earnings Guidance

Key Points

• Q3 2026 guidance: Varex issued EPS guidance of $0.150–$0.300 (consensus $0.220) and revenue guidance of $210.0M–$225.0M (consensus $215.5M).
• The company recently reported Q2 EPS of $0.21 (missed by $0.01) and revenue of $216.0M (slightly below estimates), while the stock traded at $11.81 with a market cap of about $495M and a negative trailing P/E of -7.20.
• Analyst coverage is mixed—MarketBeat shows an average rating of “Moderate Buy” with a $16.17 average price target—while insiders recently sold shares (4,510 shares; insiders own 4.6% of the stock).

Varex Imaging (NASDAQ:VREX - Get Free Report) issued an update on its third quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.150-0.300 for the period, compared to the consensus earnings per share estimate of 0.220. The company issued revenue guidance of $210.0 million-$225.0 million, compared to the consensus revenue estimate of $215.5 million.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on VREX. B. Riley Financial reissued a "buy" rating on shares of Varex Imaging in a research report on Thursday, February 12th. Jefferies Financial Group reissued a "hold" rating and issued a $14.50 price objective on shares of Varex Imaging in a research report on Monday, February 2nd. Zacks Research raised Varex Imaging from a "hold" rating to a "strong-buy" rating in a research report on Monday, April 13th. Wall Street Zen lowered Varex Imaging from a "strong-buy" rating to a "buy" rating in a research report on Saturday, April 25th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Varex Imaging in a research report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Varex Imaging has an average rating of "Moderate Buy" and an average price target of $16.17.

Varex Imaging Stock Performance

NASDAQ VREX traded down $0.36 on Thursday, hitting $11.81. The stock had a trading volume of 563,251 shares, compared to its average volume of 315,834. The company has a quick ratio of 1.87, a current ratio of 3.89 and a debt-to-equity ratio of 0.75. The company's 50-day moving average is $11.58 and its two-hundred day moving average is $12.17. The stock has a market cap of $494.84 million, a price-to-earnings ratio of -7.20 and a beta of 0.96. Varex Imaging has a one year low of $6.76 and a one year high of $14.56.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $216.00 million during the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, analysts expect that Varex Imaging will post 0.93 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Jay K. Kunkel sold 4,510 shares of the firm's stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director directly owned 23,450 shares of the company's stock, valued at $261,233. This trade represents a 16.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 4.60% of the stock is currently owned by insiders.

Institutional Trading of Varex Imaging

A number of hedge funds have recently modified their holdings of the company. Quarry LP acquired a new stake in Varex Imaging during the 3rd quarter valued at $64,000. BNP Paribas Financial Markets lifted its holdings in Varex Imaging by 18.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company's stock worth $113,000 after buying an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the third quarter worth $117,000. Cerity Partners LLC bought a new position in Varex Imaging in the second quarter valued at about $123,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company's stock worth $133,000 after buying an additional 1,442 shares during the period.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.